MedTrace Logo

Use of PET/MR Imaging in Chronic Pain

NCT03195270 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2023-05-16

No results posted yet for this study

Summary

The investigators are studying the ability of PET/MR imaging (using the PET tracer \[18F\]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.

Conditions

Interventions

DRUG

[18F]FDG

10 mCi of \[18F\]FDG via the antecubital vein in a bolus injection

DEVICE

PET/MRI

PET/MRI hybrid scanner used as diagnostic device

Sponsors & Collaborators

Principal Investigators

  • Feliks Kogan, PhD · Assistant Professor of Radiology

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-24
Primary Completion
2022-01-20
Completion
2022-01-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03195270 on ClinicalTrials.gov